Partnering to advance early detection and prevention efforts for pancreatic cancer: the Florida Pancreas Collaborative.
作者信息
Permuth Jennifer B, Trevino Jose, Merchant Nipun, Malafa Mokenge
机构信息
Department of Cancer Epidemiology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Department of Gastrointestinal Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
出版信息
Future Oncol. 2016;12(8):997-1000. doi: 10.2217/fon-2016-0045. Epub 2016 Feb 10.
Abstract
摘要
相似文献
1
Partnering to advance early detection and prevention efforts for pancreatic cancer: the Florida Pancreas Collaborative.
Future Oncol. 2016;12(8):997-1000. doi: 10.2217/fon-2016-0045. Epub 2016 Feb 10.
2
Prevention and Early Detection of Pancreatic Cancer.
Surg Clin North Am. 2018 Feb;98(1):1-12. doi: 10.1016/j.suc.2017.09.001.
3
Early detection of sporadic pancreatic cancer: summative review.
Pancreas. 2015 Jul;44(5):693-712. doi: 10.1097/MPA.0000000000000368.
4
Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper.
Pancreas. 2015 Jul;44(5):686-92. doi: 10.1097/MPA.0000000000000369.
5
Inflammation, regeneration, and transformation in the pancreas: results of the Collaborative Research Center 518 (SFB 518) at the University of Ulm.
Pancreas. 2011 May;40(4):489-502. doi: 10.1097/MPA.0b013e318214f33a.
6
[Early detection of pancreatic cancer].
Nihon Rinsho. 2006 Jan;64 Suppl 1:155-9.
7
Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention.
Gastroenterology. 2023 Apr;164(5):752-765. doi: 10.1053/j.gastro.2023.02.012. Epub 2023 Feb 18.
8
A Social Program for the Early Detection of Pancreatic Cancer: The Kishiwada Katsuragi Project.
Oncology. 2017;93 Suppl 1:89-97. doi: 10.1159/000481239. Epub 2017 Dec 20.
9
Challenges and Opportunities in Pancreatic Cancer Screening Among High-Risk Individuals.
Gastroenterology. 2022 Jun;162(7):2113-2120. doi: 10.1053/j.gastro.2022.03.040. Epub 2022 Mar 29.
10
The rise and fall of cancer mortality in the USA: why does pancreatic cancer not follow the trend?
Future Oncol. 2013 Jul;9(7):917-9. doi: 10.2217/fon.13.76.
引用本文的文献
1
Reliable Radiologic Skeletal Muscle Area Assessment - A Biomarker for Cancer Cachexia Diagnosis.
medRxiv. 2025 Apr 25:2025.04.21.25326162. doi: 10.1101/2025.04.21.25326162.
2
A pilot study to troubleshoot quality control metrics when assessing circulating miRNA expression data reproducibility across study sites.
Cancer Biomark. 2022;33(4):467-478. doi: 10.3233/CBM-210255.
3
The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer.
Cancers (Basel). 2021 Feb 15;13(4):809. doi: 10.3390/cancers13040809.
4
Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas.
Lab Invest. 2021 Feb;101(2):204-217. doi: 10.1038/s41374-020-00494-1. Epub 2020 Oct 9.
5
Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer Center.
Gastrointest Disord (Basel). 2019 Mar;1(1):106-119. doi: 10.3390/gidisord1010008. Epub 2018 Nov 1.
6
Cancer Informatics for Cancer Centers (CI4CC): Building a Community Focused on Sharing Ideas and Best Practices to Improve Cancer Care and Patient Outcomes.
JCO Clin Cancer Inform. 2020 Feb;4:108-116. doi: 10.1200/CCI.19.00166.
7
Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities.
Cancer Med. 2019 Jun;8(6):3314-3324. doi: 10.1002/cam4.2180. Epub 2019 May 9.
8
Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma.
Oncotarget. 2018 May 1;9(33):23078-23090. doi: 10.18632/oncotarget.25212.
9
Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Sci Rep. 2017 Sep 5;7(1):10484. doi: 10.1038/s41598-017-09754-5.
本文引用的文献
1
Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Cancer Prev Res (Phila). 2015 Sep;8(9):826-34. doi: 10.1158/1940-6207.CAPR-15-0094.
2
International Consensus Guidelines parameters for the prediction of malignancy in intraductal papillary mucinous neoplasm are not properly weighted and are not cumulative.
HPB (Oxford). 2014 Oct;16(10):929-35. doi: 10.1111/hpb.12305. Epub 2014 Jul 30.
3
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Cancer Res. 2014 Jun 1;74(11):2913-21. doi: 10.1158/0008-5472.CAN-14-0155.
4
Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
Ann Surg. 2013 Sep;258(3):466-75. doi: 10.1097/SLA.0b013e3182a18f48.
5
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas.
Pancreatology. 2012 May-Jun;12(3):183-97. doi: 10.1016/j.pan.2012.04.004. Epub 2012 Apr 16.
6
Cystic precursors to invasive pancreatic cancer.
Nat Rev Gastroenterol Hepatol. 2011 Mar;8(3):141-50. doi: 10.1038/nrgastro.2011.2.
7
The incidental pancreatic cyst.
Radiol Clin North Am. 2011 Mar;49(2):349-59. doi: 10.1016/j.rcl.2010.10.008. Epub 2011 Jan 11.
8
Proteomics in pancreatic cancer research.
Proteomics. 2011 Feb;11(4):816-28. doi: 10.1002/pmic.201000401. Epub 2011 Jan 13.
9
Design and utilization of the colorectal and pancreatic neoplasm virtual biorepository: An early detection research network initiative.
J Pathol Inform. 2010 Oct 1;1:22. doi: 10.4103/2153-3539.70831.
10
Multi-institutional tumor banking: lessons learned from a pancreatic cancer biospecimen repository.
Pancreas. 2010 Oct;39(7):949-54. doi: 10.1097/MPA.0b013e3181df27a8.
Zotero 插件